04-Oct-2003
HOME, NEWSLETTER
AIM & SCOPE
BOARD OF EDITORS
INSTRUCTIONS
VOL.24, 2003 CONTENTS
VOL.23, 2002
VOL.22, 2001
VOL.21, 2000
VOL.20, 1999
VOL.19, 1998
VOL.18, 1997
ETHOLOGY
PRESS ROOM
CONTACT
SUBSCRIBE - ORDER

NEUROENDOCRINOLOGY LETTERS
including Psychoneuroimmunology, Neuropsychopharmacology,
Reproductive Medicine, Chronobiology
and Human Ethology, ISSN 0172–780X

NEL Vol.24 Nos.3/4, Jun-Aug 2003

ORIGINAL ARTICLE

17-b estradiol down regulates ganglionic microglial cells via nitric oxide release

2003; 24:130136
pii: NEL243403A01
PMID: 14523344

[Read pdf 218kb]

Buy article
Check Out

Related PRESS RELEASE
Related Articles in this issue:
1. Preface - Guest Editorial
by Stefano
2. Stefano et al
(below)| 3. Zhu et al | 4. Cho et al - Review

 

17-b estradiol down regulates ganglionic microglial cells via nitric oxide release:
Presence of an estrogen receptor b transcript

George B. Stefano, Wei Zhu, Kirk Mantione, Dolisha Jones,
Elliott Salamon, John J. Cho & Patrick Cadet

Neuroscience Research Institute, State University of New York College at Old Westbury, Old Westbury, New York, USA;

Submitted: July 22, 2003
Accepted: July 31, 2003

Key words:
17-b-estradiol; estrogen cell surface receptors; nitric oxide; estrogen receptor-b; microglia; immune activation

 

Abstract

OBJECTIVES: In earlier studies we have demonstrated that 17-b-estradiol and an estrogen cell surface receptor can be found on various human cells where they are coupled to nitric oxide release. We also demonstrated the presence of estrogen signaling in Mytilus edulis ganglia. In the present report, we sought to determine a function for these ganglionic estrogen receptors, transcending a reproductive role for estrogen.


MATERIAL & METHODS: Ganglionic microglial egress from excised pedal ganglia was examined microscopically following pharmacological treatments designed to determine a role for 17-b-estradiol in microglial regulation via nitric oxide.
Additionally, we examined the tissue by RT-PCR and sequence analysis for the estrogen receptor b gene.


RESULTS: In ganglia incubated with varying concentrations of 17-b-estradiol-BSA there is a significant drop in microglial egress at the 24 hour observation period (58.7 ± 7.4 vs. 17-b-estradiol-BSA exposed = 14.7 ± 1.5; P<0.01), which can be antagonized by tamoxifen and significantly diminished by L-NAME, a nitric oxide synthase inhibitor. By RT-PCR and sequence analysis Mytilus edulis pedal ganglia was found to express a 266 bp fragment of the estrogen receptor-b gene, which exhibits 100% sequence identity with the human counterpart.


CONCLUSION: These data suggest that 17-b-estradiol-BSA is working on estrogen cell surface receptors since 17-b-estradiol-BSA does not enter the cytoplasm and that these receptors are coupled to constitutive nitric oxide release. This study demonstrates that 17-b-estradiol can down regulate microglial fMLP induced activation and activation following ganglionic excision.

__________________________________________________________
Copyright  Neuroendocrinology Letters 2003
Society of Integrated Sciences
All rights reserved. No part may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or ortherwise, without prior written permission from the Editor-in-Chief.
The latest statistics from the www.nel.edu